Perrigo (PRGO) Share-based Compensation Growth (3y) (2016 - 2026)
Perrigo (PRGO) Share-based Compensation Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 10.06% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 9.14% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 0.43% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -8.13% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -1.73% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -8.04% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Perrigo | 1.98 Bn | 1.58 Bn | 313.90 Mn | -28.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -28.50% |
| Mar 28, 2026 | -16.69% |
| Dec 31, 2025 | -66.80% |
| Sep 27, 2025 | -44.57% |
| Jun 28, 2025 | 14.47% |
| Mar 29, 2025 | -23.23% |
| Dec 31, 2024 | -63.04% |
| Sep 28, 2024 | -60.39% |
| Jun 29, 2024 | 17.72% |
| Mar 30, 2024 | -14.55% |
| Dec 31, 2023 | -10.12% |
| Sep 30, 2023 | 1.16% |
| Jul 1, 2023 | 11.27% |
| Apr 1, 2023 | 15.41% |
| Dec 31, 2022 | -10.14% |
| Oct 1, 2022 | -10.01% |
| Jul 2, 2022 | -10.99% |
| Apr 2, 2022 | 28.48% |
| Dec 31, 2021 | -3.74% |
| Oct 2, 2021 | 37.18% |